Shareholding disclosure

Molecular Partners AG

Declared position

Threshold

Fell below threshold

Timeline

Published

15.07.2020

Transaction

10.07.2020

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAK7D00041

Beneficial owner

Molecular Partners AG

Declared address

Molecular Partners AG, 8952 Schlieren-Zürich

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Molecular Partners AG

Molecular Partners AG15.07.2020TAK7D00041

Disclosure summary

Molecular Partners AG disclosed a holding in Molecular Partners AG that fell below the publication threshold, published by SIX Exchange Regulation on 15.07.2020, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Molecular Partners AG disclosed a holding in Molecular Partners AG, published on 15.07.2020.

Publication date15.07.2020

Transaction date10.07.2020

Issuing companyMolecular Partners AG

Beneficial ownerMolecular Partners AG

Declared addressMolecular Partners AG, 8952 Schlieren-Zürich

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAK7D00041

Commercial register

CHE-112.115.136

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 15.07.2020

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open